Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2005
07/20/2005CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same
07/20/2005CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors
07/20/2005CN1211126C Vascular endothelial growth factor 2
07/20/2005CN1211119C Compound pill medicine for treating hemorrhoids and use
07/20/2005CN1211108C Chinese patent drug for treating thrombus obliterating angiitis
07/20/2005CN1211107C Mixture for improving blood circulation
07/20/2005CN1211091C Polyallylamine polymers for treating hypercholesterolemia
07/20/2005CN1211086C Sustained release ranolazine formulations
07/19/2005US6919461 Anticancer agents; antiarthritic agents
07/19/2005US6919432 Substances and their uses
07/19/2005US6919378 Pharmaceutical solutions of modafinil compounds
07/19/2005US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
07/19/2005US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders
07/19/2005US6919369 Controlling blood coagulation
07/19/2005US6919367 Substituted thioacetamides
07/19/2005US6919363 Central nervous system disorders; antiischemic agents; analgesics
07/19/2005US6919362 For use as hypoglycaemic and hypolipidaemic agents
07/19/2005US6919360 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system
07/19/2005US6919355 Amide derivatives as NMDA receptor antagonists
07/19/2005US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
07/19/2005US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents
07/19/2005US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
07/19/2005US6919345 Sulfonate substituted pyrazol pyridine derivatives
07/19/2005US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
07/19/2005US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents
07/19/2005US6919339 ABCA-1 elevating compounds
07/19/2005US6919335 Heterocycles that are inhibitors of IMPDH enzyme
07/19/2005US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents
07/19/2005US6919330 Formulations of drugs
07/19/2005US6919327 Texaphyrin coordination compounds and uses thereof
07/19/2005US6919324 Functionalized stilbene derivatives as improved vascular targeting agents
07/19/2005US6919310 Administering drug formulation comprising opioidergic agent and an insulin secretagogue for therapy of human suffering from one or more conditions included within Coronary Heart Disease Risk Factor Syndrome
07/19/2005US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
07/19/2005US6919100 Method for coating medical devices
07/19/2005US6919094 Composition of medicine for treating headache disease and process of preparation and uses thereof
07/19/2005US6919087 And an excipient wherein the pH is within the range of 5.5-7.0; stability; dosage forms
07/19/2005US6918927 Coated implantable medical device
07/14/2005WO2005063737A1 Amidopyrazole derivative
07/14/2005WO2005063736A1 Aminoalkylpyrazole derivative
07/14/2005WO2005063725A1 Phenylpropanoic acid derivatives
07/14/2005WO2005063704A1 Azetidine ring compounds and drugs comprising the same
07/14/2005WO2005063302A1 Drug for preventing or treating heart diseases comprising cd9 gene
07/14/2005WO2005063270A1 Composition comprising an aqueous extract of red vine leaves and a diuretic for the treatment of chronic venous insufficiences
07/14/2005WO2005063269A1 Composition comprising an aqueous extract of red vine leaves and a antithrombotic agent for the treatment of chronic venous insufficiences
07/14/2005WO2005063268A1 Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent for the treatment of chronic venous insufficiences
07/14/2005WO2005063267A1 The oral disintegratable tablet of ginkgo leaves
07/14/2005WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates
07/14/2005WO2005062824A2 Anti-hypercholesterolemic compounds
07/14/2005WO2005034837A3 7H-IMIDAZO [1,2-α] PYRAZIN-8-ONE COMPOUNDS AS ION CHANNEL MODULATORS
07/14/2005WO2004058770A8 Triptolide derivatives and their use
07/14/2005WO2004048386A9 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS
07/14/2005WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/14/2005WO2003029424A3 Novel proteins and nucleic acids encoding same
07/14/2005US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders
07/14/2005US20050155087 Method of screening compounds
07/14/2005US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance
07/14/2005US20050154230 Urea derivatives
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154165 Ph-sensitive polymer
07/14/2005US20050154062 Substituted chiral allosteric hemoglobin modifiers
07/14/2005US20050154061 peroxisome-proliferator-activated receptor (PPAR)-delta agonist; 2-[4-[[[2-[(2,4-Dichlorophenyl)amino]-2-oxoethyl]cyclohexylamino]methyl]-2-methylphenoxy]-2-methylpropanoic acid; cardiovascular disorders, dyslipidaemias or restenosis; improves HDL/LDL cholesterol ratio; side effect reduction
07/14/2005US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis
07/14/2005US20050154045 E.g., N-[4-(2-Thienyl)phenyl]-1-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride; treatment of impairments of perception, concentration, learning and/or memory
07/14/2005US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
07/14/2005US20050154028 1-(3-Fluoro-phenyl)-3-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-2-one; serotonin 5-ht2c receptor antagonist; antidepressant and anxiolytic agent
07/14/2005US20050154026 Suitable for the treatment of gastric and intestinal disorders; in particular, omeprazole, rabeprazole, pantoprazole, esomeprazole
07/14/2005US20050154025 6-[4-(fluoro- or trifluoromethyl)pyridyl-4-(p-fluorophenyl)-5-methylimidazol-2-yl] pyridones; cyclization of 1-phenyl-1-pyridyl-1,2-diaminopropanes with an acid, amidine, or nitrile compound; neuropeptide Y receptor antagonists; cardiovascular and central nervous system disorders, metabolic diseases
07/14/2005US20050154019 Substituted cyclic amine metalloprotease inhibitors
07/14/2005US20050154018 Method for treating and preventing disorders using optically pure (+) norcisapride
07/14/2005US20050153996 Compounds that modulate ppar activity and methods for their preparation
07/14/2005US20050153993 Treatment of statin side effects using uridine derivatives
07/14/2005US20050153987 Compounds
07/14/2005US20050153982 Sustained release ranolazine formulations
07/14/2005US20050153980 Substituted indoles
07/14/2005US20050153978 Medicaments
07/14/2005US20050153965 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/14/2005US20050153964 Novel compounds
07/14/2005US20050153960 Substituted arylamine derivatives and methods of use
07/14/2005US20050153952 Methods for inhibiting sterol absorption
07/14/2005US20050153941 Cell differntiation inhibiting agent, cell culture method using the same, culture medium, and cultured cell line
07/14/2005US20050153930 Via gadolinium compounds as calcium channel blockers; drug screening
07/14/2005US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits
07/14/2005US20050153902 Inhibitors of integrin avb6
07/14/2005US20050153889 Modulation of pericyte proliferation
07/14/2005US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells
07/14/2005US20050153886 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy
07/14/2005US20050153884 Methods of therapy with thrombin derived peptides
07/14/2005US20050153878 Fgfr agonists
07/14/2005US20050153871 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow
07/14/2005US20050153870 Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome
07/14/2005US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders
07/14/2005US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders
07/14/2005US20050152978 Capsule, tablet with enteric, protective coatings; bioavailability
07/14/2005US20050152959 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
07/14/2005US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis
07/14/2005CA2551657A1 Composition comprising an aqueous extract of red vine leaves and a antithrombotic agent for the treatment of chronic venous insufficiences
07/14/2005CA2551611A1 Thiazole derivatives for treating or preventing parkinson's disease
07/14/2005CA2551604A1 Amidopyrazole derivative
07/14/2005CA2551580A1 Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent for the treatment of chronic venous insufficiences
07/14/2005CA2551552A1 5-ht2 receptors modulators, their pharmaceuticals compositions and their use for the treatment of cardiovascular and muscle diseases
1 ... 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 ... 1595